CA2319079A1 - Pollen specific promoter - Google Patents
Pollen specific promoter Download PDFInfo
- Publication number
- CA2319079A1 CA2319079A1 CA002319079A CA2319079A CA2319079A1 CA 2319079 A1 CA2319079 A1 CA 2319079A1 CA 002319079 A CA002319079 A CA 002319079A CA 2319079 A CA2319079 A CA 2319079A CA 2319079 A1 CA2319079 A1 CA 2319079A1
- Authority
- CA
- Canada
- Prior art keywords
- gene
- pollen
- expression
- promoter
- expression system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 112
- 230000014509 gene expression Effects 0.000 claims abstract description 94
- 241000196324 Embryophyta Species 0.000 claims abstract description 84
- 240000008042 Zea mays Species 0.000 claims abstract description 23
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 23
- 239000012634 fragment Substances 0.000 claims abstract description 20
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 19
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims abstract description 19
- 235000009973 maize Nutrition 0.000 claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 claims abstract description 19
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 18
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 5
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 33
- 239000000126 substance Substances 0.000 claims description 18
- 230000001939 inductive effect Effects 0.000 claims description 17
- 230000000694 effects Effects 0.000 claims description 16
- 230000002939 deleterious effect Effects 0.000 claims description 13
- 230000035558 fertility Effects 0.000 claims description 13
- 239000013598 vector Substances 0.000 claims description 12
- 239000003550 marker Substances 0.000 claims description 11
- 206010021929 Infertility male Diseases 0.000 claims description 10
- 208000007466 Male Infertility Diseases 0.000 claims description 10
- 230000001131 transforming effect Effects 0.000 claims description 9
- 108010016529 Bacillus amyloliquefaciens ribonuclease Proteins 0.000 claims description 8
- 230000002363 herbicidal effect Effects 0.000 claims description 7
- 239000004009 herbicide Substances 0.000 claims description 7
- 101710197404 Trehalose-phosphate phosphatase Proteins 0.000 claims description 6
- 239000000411 inducer Substances 0.000 claims description 6
- 230000008119 pollen development Effects 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 230000002103 transcriptional effect Effects 0.000 claims description 6
- 101710183938 Barstar Proteins 0.000 claims description 5
- 238000011144 upstream manufacturing Methods 0.000 claims description 5
- 108090000994 Catalytic RNA Proteins 0.000 claims description 4
- 230000000692 anti-sense effect Effects 0.000 claims description 4
- 102000053642 Catalytic RNA Human genes 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 108091092562 ribozyme Proteins 0.000 claims description 3
- 101710103970 ADP,ATP carrier protein Proteins 0.000 claims description 2
- 101710133192 ADP,ATP carrier protein, mitochondrial Proteins 0.000 claims description 2
- UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 claims description 2
- 108010034634 Repressor Proteins Proteins 0.000 claims description 2
- 102000009661 Repressor Proteins Human genes 0.000 claims description 2
- 108020000999 Viral RNA Proteins 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims description 2
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 claims description 2
- 230000008436 biogenesis Effects 0.000 claims description 2
- UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 claims description 2
- 230000000749 insecticidal effect Effects 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 239000003053 toxin Substances 0.000 claims description 2
- 231100000765 toxin Toxicity 0.000 claims description 2
- 108700012359 toxins Proteins 0.000 claims description 2
- 241001136782 Alca Species 0.000 claims 1
- 101001059240 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Site-specific recombinase Flp Proteins 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 230000009466 transformation Effects 0.000 abstract description 12
- 238000011426 transformation method Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 22
- 230000009261 transgenic effect Effects 0.000 description 18
- 239000002299 complementary DNA Substances 0.000 description 14
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 9
- 230000010153 self-pollination Effects 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
- 241000208125 Nicotiana Species 0.000 description 8
- 229930027917 kanamycin Natural products 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 239000000499 gel Substances 0.000 description 6
- 208000000509 infertility Diseases 0.000 description 6
- 230000036512 infertility Effects 0.000 description 6
- 208000021267 infertility disease Diseases 0.000 description 6
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 238000010186 staining Methods 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 230000011278 mitosis Effects 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 108020004410 pectinesterase Proteins 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 238000000782 polymeric membrane extraction Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 101100437498 Escherichia coli (strain K12) uidA gene Proteins 0.000 description 3
- 238000000636 Northern blotting Methods 0.000 description 3
- 108700001094 Plant Genes Proteins 0.000 description 3
- 101710145348 Putative glutamate-cysteine ligase 2 Proteins 0.000 description 3
- 240000003768 Solanum lycopersicum Species 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005204 segregation Methods 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000023409 microsporogenesis Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000010152 pollination Effects 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- 101150040471 19 gene Proteins 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 108020005029 5' Flanking Region Proteins 0.000 description 1
- 108010024957 Ascorbate Oxidase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000010831 Cytoskeletal Proteins Human genes 0.000 description 1
- 108010037414 Cytoskeletal Proteins Proteins 0.000 description 1
- 238000000116 DAPI staining Methods 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 108700009124 Transcription Initiation Site Proteins 0.000 description 1
- 240000000359 Triticum dicoccon Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000005200 bud stage Effects 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 108020001778 catalytic domains Proteins 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012505 colouration Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000009402 cross-breeding Methods 0.000 description 1
- 230000010154 cross-pollination Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000003145 cytotoxic factor Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000002616 endonucleolytic effect Effects 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 108010060641 flavanone synthetase Proteins 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012737 microarray-based gene expression Methods 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000012243 multiplex automated genomic engineering Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000011824 nuclear material Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 108010087558 pectate lyase Proteins 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 229940121649 protein inhibitor Drugs 0.000 description 1
- 239000012268 protein inhibitor Substances 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 101150086905 rst gene Proteins 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/823—Reproductive tissue-specific promoters
- C12N15/8231—Male-specific, e.g. anther, tapetum, pollen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8237—Externally regulated expression systems
- C12N15/8238—Externally regulated expression systems chemically inducible, e.g. tetracycline
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
- C12N15/8289—Male sterility
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A recombinant nucleic acid which comprises a promoter sequence of the ZmC5 gene in maize, or a variant or fragment thereof, which acts as a promoter in pollen. The DNA sequence of the promoter is depicted in figure 5. Expression cassettes and expression systems as well as transformation methods, transformed plants including the promoter sequence of the invention are also claimed. The nucleic acid may be used inter alia in the production of male sterile plants and/or hybrids as well as in the transformation of pollen.
Description
POLLEN SPECIFIC PROMOTER
The present invention relates to a promoter sequence which is specific for pollen, to constructs and transgenic plant cells and plants comprising the promoter as well as to methods of transforming pollen and controlling fertility in plants using this promoter.
In order to introduce desirable genetic traits from two plants into a single plant, such as a variety or hybrid, cross-breeding represents the traditional approach. In order to reliably obtain consistent hybrids, it is necessary to ensure that the self pollination of the parent plants does not take place.
1o This can be achieved by ensuring that one of the parent lines is male sterile. Various techniques for producing male sterility are known and have been proposed in the art. One method involves removal of the anthers or tassels of the female parent plant, either manually or mechanically. This plant may then only be fertilised by pollen from the male parent and therefore its progeny will be hybrid. However, such a process is labour intensive and not 1 s altogether reliable as it is possible that some female plants may miss the detasseling process or in some cases, the plants develop secondary tassels after detasseling has been completed.
In addition in this system the male parent is able to self pollinate so it is necessary to physically separate male and female parents to allow ease of harvest of hybrid seed. This block planting works well for corn as the pollen is light and produced in large quantity.
2o However, this approach is not applicable to species with heavier pollen and in species in which the male and female floral organs are contained within one flower e.g.
wheat, rice.
Chemical methods of preventing pollen production are also known. US Patent No.
4,801,326 describes chemicals which may be applied to the plant or soil to prevent pollen production. However, again such techniques are labour intensive and are not wholly 2s reliable. It is essential that sufficient chemical is applied at the appropriate time intervals to ensure pollination does not occur, with the concomitant burden on the environment. In addition, these chemicals are very expensive.
Genetic engineering has provided an alternative way by which male sterility can be produced, maintained and/or subsequently restored in plants.
3o Systems have been described in which inducible promoters which allow fertility to be switched on or off depending upon the application or availability of an external compound.
_7_ For example, WO 90/08830 describes the induction of male sterility in a plant by a cascade of gene sequences which express a protein which disrupts pollen biosynthesis.
WO
93/18171 describes the use of a GST promoter to inducibly express chalcone synthase (chs) and restore fertility to a male sterile plant made sterile by "knocking out"
the endogenous chs genes.
A different approach was described in W093/25695 (PGS). This relies upon the use of a tapetum specific promoter to express a pollen lethality gene, barnase, in the tapetal cells which are critical to pollen development thus disrupting pollen production. A
restorer gene, barstar, can be used to restore fertility (Mariani et al. Nature Vol 357: 384-387).
There would be advantages to expressing genes which have an impact in pollen production in pollen directly in a controllable manner. Suitably, fertility should be restorable when desired.
A component of a system to genetically engineer male sterility is the availability of a promoter which specifically drives expression either in pollen or in tissue on which pollen production or development depends.
Many of the characterised genes which are specifically or highly expressed in pollen and germinating pollen encode proteins that are likely to play a role in cell wall metabolism, for example, those having homology to genes encoding enzymes involved in pectin degradation; polygalacturonases (SM Brown et al.., Plant Cell (1990) 2: 263-274, SJ Tebbutt 2o et al.., Plant Mol. Biol. (1994) 25:283-299), pectate lyase (HJ Rogers et al.:, Plant Mol Biol 20:493-502 (1992), RA Wing et al., Plant Mol Biol 14:17-28 (1989)) and pectin methylesterase (PME) JH Mu et al.., Plant Mol Biol 25:539-544 (1994)).
Other genes highly expresed in pollen include those that encode cytoskeletal proteins (I. Lopez et al.., Proc. Natl, Acad Sci USA 93: 7415-7420 (1996), HJ Rogers et al.., Plant J.
4: 875-882 (1993) and CJ Staiger et al.., Plant J. 4: 631-641 (1993)), putative ascorbate oxidases, a Kunitz protein inhibitor and many others whose function cannot be inferred by homology to known genes. The temporal expression of such genes has been studied and many are found to be expressed late in microsporogenesis reaching a maximum in mature microsporocytes. In some cases continued expression in the pollen tube has also been 3o demonstrated (AK Kononowicz et al.., Plant Cell 4; 513-524 ( 1992)). These genes are referred to as "late genes". The majority of expression at this stage is from the vegetative cell rather than from the generative cell and it is likely that the majority of these 'late' genes are transcribed from the vegetative nucleus; although this has only been demonstrated for one "late" gene (D. Twell, Plant J2: 887-892 (1992). A distinct class of genes expressed in anthers is found to have a different expression programme, being first detectable soon after the tetrad stage and declining in expression well before pollen maturity. It is likely that the major role of these 'early' genes may be during microspore differentiation and development rather than pollen tube growth. In addition, US Patent No. 5.086,169 (Mascarenhas) describes the isolation of the frst pollen-specific promoter from com.
The applicants have isolated a further promoter which is specifically expressed only in pollen tissue. The promoter is derived from a 'late' pollen expressed gene isolated from maize, ZmCS.
Thus, according to a first aspect of the present invention there is provided a recombinant nucleic acid sequence which comprises a promoter sequence of the ZmCS gene in maize, or a variant or fragment thereof, which acts as a promoter in pollen.
t5 As used herein, the term "fragment" includes one or more regions of the basic sequence which retain promoter activity. Where the fragments comprise one or more regions, they may be joined together directly or they may be spaced apart by additional bases.
The expression "variant" with reference to the present invention means any 2o substitution of, variation of, modification of, replacement of, deletion of or the addition of one or more nucleotides from or to the nucleic acid sequence providing the resultant sequence exhibits pollen promoter expression. The term also includes sequence that can substantially hybridise to the nucleic acid sequence.
As used herein, the expression "ZmCS gene" refers to the gene of maize which 25 encodes a 563 amino acid sequence as described herein. A cDNA sequence encoding this sequence is defined in EMBL Y13285 The promoter sequence of the present invention is comprised within the clone deposited National Collection of Industrial and Marine Bacteria as NCIMB 40915 on 26 Jan 1998. This is a Sal I fragment derived as described hereinafter. The promoter region lies 3o within a region which consists of approximately 2kb of sequence upstream of the transcription start site of the ZmCS gene of maize as shown in Figure 1 hereinafter.
WO 99/42587 - ~ PCT/GB99/00232 According to a preferred embodiment of the present invention, there is provided a recombinant nucleic acid sequence which comprises a promoter sequence comprising at least part of the DNA sequence as shown in Figure 5 or at least part of a sequence encoding a promoter which has substantially similar activity to the promoter encoded by Figure 5 or a variant or fragment thereof.
The term "substantially similar activity" includes DNA sequences which are complementary to and hybridise to the DNA of the present invention and which code for a promoter which acts in pollen. Preferably, such hybridisation occurs at, or between, low and high stringency conditions. In general terms, low stringency conditions can be defined as 3 x 1o SCC at ambient temperature of between about 60°C to about 65°C, and high stringency conditions as 0.1 x SSC at about 65°C. SSC is the name of a buffer of O.15M NaCI, 0.01 SM
trisodium citrate. 3 x SSC is three times as strong as SSC and so on.
The pollen specific promoter of the present invention may be used to engineer male sterility by driving genes capable of interfering with pollen production or viability, or to 15 express genes of interest specifically in pollen grains.
According to a second aspect of the present invention, the promoter sequence may form part of an expression cassette in combination with genes whose expression in pollen, and particularly in late pollen production, may be desirable. These include genes which have an impact on pollen or pollen production. Such genes may be those involved in the control 20 of male-fertility, genes which encode insecticidal toxins (which would then be targeted to insect species which feed on pollen), or genes which would enhance or modify the nutritional value of the pollen. In addition, the promoter sequence could be used to drive expression of a selectable marker for use in pollen transformation. Examples of suitable selectable marker genes include antibiotic resistance genes such as kanamycin resistance gene, hygromycin 25 resistance gene and the PAT resistance gene so as to enable stable transformants to be identified depending on the species e.g. corn, rice, wheat.
The term "expression cassette" - which is synonymous with terms such as "DNA
construct", "hybrid" and "conjugate" - includes an effect gene directly or indirectly attached to the regulator promoter, such as to form a cassette. An example of an indirect attachment is 3o the provision of a suitable spacer group such as an intron sequence intermediate the promoter and the target gene. The DNA sequences may furthermore be on different vectors and are therefore not necessarily located on the same vector. The same is true for the term "fused" in relation to the present invention which includes direct or indirect attachment. Such constructs also include plasmids and phage which are suitable for transforming a cell of interest.
According to a preferred embodiment, expression cassettes of the present invention comprise a promoter sequence as described above which is arranged to control expression of a gene which is deleterious to pollen development, such as genes encoding barnase, adenine nucleotide translocator, mutant tubulins, T-urf (as claimed in WO 97/04116) or trehalose phosphate phosphatase (TPP).
1o For instance, W093/25695 describes the use of the gene barnase which encodes a cytotoxic protein , which is under the control of a tapetum specific promoter.
Expression of barnase in the tapetal cells disrupts these cells and leads to disruption of pollen production.
Ribozymes are RNA molecules capable of catalysing endonucleolytic cleavage reactions. They can catalyse reactions in trans and can be targeted to different sequences.
15 They are therefore potential alternatives to antisense as a means of modulating gene expression. (Hasselhof and Gerlach (1988) Nature Vol 334: 585-591) or Wegener et al.
(1994) Mol Gen Genet 245: (465-470) have demonstrated the generation of a trans -dominant mutation by expression of a ribozyme gene in plants. If required, the pollen specific promoter of the present invention may be used to control expression of the ribozymes such 2o that they are specifically expressed in pollen.
Baulcombe (1997) describes a method of gene silencing in transgenic plants via the use of replicable viral RNA vectors (AmpliconsT"') which may also be useful as a means of knocking out expression of endogenous genes. This method has the advantage that it produces a dominant mutation i.e. is scorable in the heterozygous state and knocks out all 25 copies of a targeted gene and may also knock out isoforms. This is a clear advantage in wheat which is hexaploid. Fertility could then be restored by using an inducible promoter to drive the expression of a functional copy of the knocked out gene. By including the pollen specific promoter as the elements of the AmpliconT"" vector, expression of the gene would then take place specifically in the pollen.
3o The use of cytotoxic or disrupter genes as means of disrupting pollen production requires the expression of restorer genes to regain fertility. Suitably the construct further comprises a cassette comprising a nucleotide sequence which is able to overcome the effect of said deleterious gene, such as a restorer gene such as barstar in the case of barnase or TPS
in the case of TPP, or a sequence which encodes a construct which is sense or antisense to a deleterious gene.
An alternative means of controlling expression of deleterious genes is to use operator sequences. Operator sequences such as lac, tet, 434 etc. may be inserted into promoter regions as described in WO 90/08830. Repressor molecules can then bind to these operator sequences and prevent transcription of the downstream gene, for example a gene deleterious to pollen development (Wilde et al. ( 1992) EMBO J. 11, 1251 ). Furthermore, it is possible to 1 o engineer operator sequences with enhanced binding capacity such as the Lac IO His mutant as described in (Lehming et al. (1987) EMBO . 6, 3145-3153). This has a change of amino acid from tyrosine to histidine at position 17 thus giving tight control of expression. Used in combination with inducible expression of the repressor this then allows expression of an inactivating gene to be turned off.
15 In this way, the expression cassettes may be incorporated into expression systems which may be used in the control of fertility of a plant as described above.
The term "expression system" means that the system defined above can be expressed in an appropriate organism, tissue, cell or medium. The system may comprise one or more expression cassettes and may also comprise additional components that ensure to increase 2o expression of the target gene by use of the regulator promoter.
According to a third aspect of the present invention, there is provided an expression system comprising (a) a first promoter sequence which is expressed specifically in pollen;
(b) a first gene which, when expressed, disrupts pollen biogenesis. under the control of said 25 pollen specific promoter;
(c) a second promoter sequence responsive to the presence or absence of an exogenous chemical inducer; and (d) a second gene encoding an element which can inhibit either expression of said first gene, or can inhibit the protein coded for by said f rst gene, operably linked to and under the 3o control of said second promoter sequence.
_'7_ Elements (a) and (b) and (c) and (d) above may be provided by one or two individual vectors, but preferably are contained in the same vector to ensure co-segregation. These can be used to transform or co-transform plant cells so as to allow the appropriate interaction between the elements to take place.
The second promoter sequence and the second gene provide for chemical "switching" on and off of the first gene. Where the second promoter sequence is responsive to the presence of the exogenous chemical inducer, application of the chemical inducer to pollen or to a plant will have the effect of switching on the second gene which thereby counteracts the effect of the first gene. The absence of the chemical inducer will have a 1 o similar effect where the second promoter sequence is active only in the absence of the chemical inducer.
Elements (c) and (d) are suitably in the form of an expression cassette comprising a nucleotide sequence which is able to overcome the effect of said deleterious gene, such as a restorer gene such as barstar in the case of barnase or TPS in the case of TPP, or a sequence 15 which encodes a construct which is sense or antisense to a deleterious gene, or a gene encoding a repressor molecule in the case of operator sequences being used operatively interconnected with an inducible promoter.
The expression system of the present invention may further comprise a selectable marker, such as herbicide resistance genes or antibiotic resistance genes so as to allow stable 2o transformants to be identified depending on the species eg corn, rice, wheat. The presence of a herbicide resistance gene also allows selection of male sterile progeny in a segregating population.
Transformation of a plant with such an expression system will result in the production of male sterile plants and methods of producing such a plant form a fourth aspect 25 of the present invention.
Expression systems in accordance with this embodiment of the present invention, wherein the gene is deleterious to viable pollen production, are useful in the production of hybrids but are especially useful when the male sterile line can be made homozygous. When "late" promoters, such as the ZmCS promoter described above, are used, because the gene 3o products are expressed late in pollen development, primary transformants and heterozygotes _g_ produce pollen which segregates I :1 for sterility i.e. 50% of the pollen is fertile and so self pollination leading to non-hybrid seed may occur.
In order to obtain a homozygous sterile plant, the inducible promoter must be switched on to drive expression of the restorer gene using the appropriate chemical such as ethanol in the case of the AIcAlR switch or safener for the GST switch. This then inactivates the deleterious gene, so allowing self pollination to occur in accordance with the model below.
MS = Dominant male sterility 1 o Rcs = inducible restorer Heterozygous genotype MSRcs---Gametes MSRcs ---~ 5 Self pollination after chemical induction gives MSRcs ---MSRcs MSMSRcsRcs ---MSRcs --- MSRcs--- --- ---All pollen from the homozygous progeny (MSMSRcsRcs) will be sterile. 50% of the pollen from the heterozygous progeny (MSRcs---) will be sterile. All of the pollen from the null (--- ---) progeny will be fertile. Staining of the pollen from these lines with a vital stain such as DAPI will allow identification of the plant producing 100% sterile pollen.
Alternatively, the induction and self pollination can be repeated on this segregating population and the progeny analysed for segregation of sterility. Clearly all progeny deriving from self pollination of the homozygous line will themselves be homozygous and male 3o sterile i.e. they will all produce 100% sterile pollen, whereas progeny arising from self pollination of a heterozygous line will continue to segregate for sterility.
Alternatively, if the WO 99/42587 _ 9 _ PCT/GB99/00232 gene giving rise to male sterility is linked to a gene conferring herbicide resistance, then progeny may be sprayed with herbicide at an early seedling stage, herbicide tolerance will segregate with the sterility gene. In this way, male sterile parents can be identified and selected for hybrid production.
Once identified, this homozygous sterile line may be used in the production of F I
hybrids by cross pollination by an unmodified inbred male parent line. See below.
Female parent Male parent MSMSRcsRcs *** ***
to Gametes MSRcs MSRcs MSRcs *** MSRcs*** MSRcs***
Fl *** MSRcs*** MSRcs***
Thus, all the F 1 seed is hybrid and heterozygous for sterility, meaning that 50% of the 2o pollen from each plant is fertile. In a crop species such as corn this is ample viable pollen to ensure complete pollination across a field due to the sheer volume of pollen produced by each tassel. In wheat too this should be sufficient pollen to ensure no yield loss as self pollination occurs while the flower is still closed, thus reducing loss by wind etc. In species in which the vegetative part of the plant is harvested then reduced pollen viability is not a factor to be taken into account.
There is too an additional benefit to the hybrid seed producer in that should the farmer retain F2 seed for subsequent planting he will suffer a loss in yield as result of loss of heterosis. See below.
WO 99/42587 _ 1 O _ PCT/GB99/00232 F 1 MSRcs***
Gametes MSRcs (not viable) MSRcs none * * * MSRcs *** none *** ***
These methods may allow for reversal of the sterility, for example in hybrid production, by activation using an inducible promoter.
According to a fifth aspect of the present invention, there is provided a method of 1o controlling the fertility of a plant which comprises transforming said plant with an expression system as described above, and when fertility is to be restored, activating the inducible promoter.
Suitable inducible promoters include those which are controlled by the application of an external chemical stimulus, such a herbicide safener. Examples of inducible promoters t5 include, for example, a two component system such as the alcAlalcR gene switch promoter system described in our published International Publication No. WO 93/21334, the ecdysone switch system as described in our International Publication No. WO 96/37609 or the GST
promoter as described in published International Patent Application Nos. WO
90/08826 and WO 93/031294, the teachings of which are incorporated herein by reference.
Such promoter 2o systems are herein referred to as "switch promoters". The switch chemicals used in conjunction with the switch promoters are agriculturally acceptable chemicals making this system particularly useful in the method of the present invention.
If the pollen specific promoter of the present invention is used to obtain male sterility, full restoration of fertility may not be achievable by this method as pollen is haploid. This 25 means that only 50% of pollen produced following activation of the restorer gene is fertile.
This may be countered by the fact that expression using the promoter of the present invention is highly tissue specific.
This property makes the use of the promoter of the present invention particularly useful in some very particular applications. For example, in some cases transformation of 3o pollen is required. In this instance the use of the pollen specific promoter be may highly desirable. An example of such an application is known as MAGE LITER (male germ line transformation) and is described by Stoger et al. (Plant Cell Reports 14 (1995) 273-278). In this method, pollen is transformed by microprojectile bombardment. A pollen specific promoter is used to drive, for example a selectable marker gene. The fact that the promoter is pollen specific confers several advantages. First of all, the marker is expressed only in the pollen, not the rest of the plant and so the remaining plant tissue does not contain unwanted marker. Furthermore, having a selectable marker only in the pollen allows the possibility of retransforming by the usual methods and not having to have a different selectable marker, i.e.
it allows easier gene stacking. The reasons why pollen transformation is important are that pollen can be made to undergo sporophytic development i.e. will give rise to haploid and t o doubled haploid plants. This means that homozygosity is achieved in one step.
Alternatively, the transformed pollen can be used to pollinate wildtype plants thus giving seed carrying the introduced transgene, again a faster process than the traditional transformation route.
The expression systems of the present invention can be introduced into a plant or t s plant cell via any of the available methods including infection by Agrobacterium tumefaciens containing recombinant Ti plasmids, electroporation, microinjection of plant cells and protoplasts, microprojectile bombardment, bacterial bombardment, particularly the "fibre" or "whisker" method, and pollen tube transformation, depending upon the particular plant species being transformed. 'The transformed cells may then in suitable cases be 2o regenerated into whole plants in which the new nuclear material is stably incorporated into the genome. Both transformed monocot and dicot plants may be obtained in this way.
Reference may be made to the literature for full details of the known methods.
Such methods form a further aspect of the present invention.
The method of the present invention would be useful in the production of a wide 25 range of hybrid plants, such as wheat, rice, corn, cotton, sunflower, sugar beet, and lettuce, oil seed rape and tomato.
Plant cells which contain a plant gene expression system as described above, together with plants comprising these cells form further aspects of the invention.
According to a nineth aspect of the present invention there is provided a replicable 3o viral DNA vector (AmpliconT"") which comprises a recombinant nucleic acid as defined above.
According to a tenth aspect of the present invention, there is provided a method of transforming pollen cells with an expression system as described above.
The invention will now be particularly described only by way of example with reference to the accompanying drawings in which:-Figure 1 is a diagram showing the alignment of the ZmCS cDNA with a 2.4kb fragment from the 5'region of its corresponding gene. The transcriptional start point is indicated (*), and the putative translational start is underlined. Sa= Sal I, S=Sma I, Sp= Sph I, H = Hind III, X =
Xho I, P = Pst I;
to Figure 2 shows a Southern blot of maize (inbred line A188) genomic DNA. Each lane contains l5pg of genomic DNA digested in lane 1 with Eco RI, in lane 2 with Hind III, and in lane 3 with Bam HI. The Southern blot was hybridised with radiolabelled ZmCS cDNA
probe.
t5 Figure 3 shows ethidium bromide stained gels showing the 18S RNAs of various maize tissue total RNAs and the northern blots of the same gels probed with the ZmCS
cDNA
probe.
(A) the gel was loaded with 10~g of total RNA from various maize tissues.
20 (B) the gel was loaded with l Opg of total RNA isolated from shoot, a developmental staged series of spikelets, pollen and germinating pollen.
Figure 4 shows (A) Physical map of the ZmCS::uidA construct and junction sequence. The A
residues by *, 25 t and ~ correspond to the ZmCS transcription start point, the T to A
mutation to remove the Hind III site (for ease of cloning) and the 3' terminus of the ZmCS promoter region, respectively. The uidA translation start is underlined.
(B) Histochemical analysis of GUS activity in pollen from transgenic ZmCS::uidA tobacco 3o showing segregation of the blue staining.
WO 99/42587 PC1'/GB99/00232 (C) Promoter activity of ZmCS in transgenic tobacco tissues from two transgenic lines, GCS-2( unfilled columns) and GCS-7 (filled columns). Data from each line represents the mean from two independent assays, normalised to a non-transgenic control. Bud stages are as follows: Bud-1 corresponds to buds of 5-8mm, (microspores at meiosis/tetrad stage), Bud-2: buds of 10-l2mm (uninucleate microspores), Bud-3: 13-lSmm, (microspore mitosis), Bud-4: (17-22mm) early- to mid-stage binucleate gametophyte, Bud-5: (27-45mm) mit- to late stage binucleate gametophyte (Tebbutt et al.., supra.).
Figure 5 shows the DNA sequence encoding the ZmCS promoter sequence in maize.
1o The underlined A is the putative transcriptional start point and the bold and underlined ATG
is the translational start point.
Figure 6 shows an expression cassette comprising CS-barnase/barstar-nos.
15 ZmCS cDNA and genomic clones Maize (inbred line A188) pollen and germinating pollen (HJ Rogers et al.., Plant J4 (1993) 875-882) cDNA libraries were screened using cDNA probes made to pollen and shoot poly(A)+ RNA following standard procedures (FM Ausubel et al.., Current protocols in Molecular Biology, Wiley, New York (1990)). All clones, totalling 1,101, that showed 2o hybridisation to the radiolabelled pollen cDNA but not to the radiolabelled shoot DNA were picked. Random colonies were picked and sequenced at the 5' end and the sequence compared on current databases. One clone which had an insert of 800bp showed significant sequence identity with known pectin methyl esterases. The pollen cDNA library was re-screened with this cDNA insert and the full length ZmCS clone (ZmCSc) was identified and 25 sequenced.
A maize (inbred line B73) genomic library (8x106 plaques) was screened using a PCR
fragment corresponding to the 5' 270bp of cDNA clone ZmCSc labelled by random priming (Ausubel et al.., supra). One positive clone ZmCSg was plaque purified.
Comparison of the sequence of a 2.Skb SaII fragment of ZmCSg subcloned into pUCl9 with ZmCSc (and 3o deposited as NCIMB 40915) showed that the two sequences overlapped and that they were identical, indicating that the clones represent the same gene. A
representation of the overlap between the 2.Skb fragment of the genomic clone with the cDNA is shown in Figure I .
A transcriptional start point was mapped using two oligonucleotide primers complementary to nucleotides I to 21 (5'- ACCTAGGAGAGCCTTTGCCAT-3') and 56 to 82 (5'-AGCGGGTGACGGTGGCGACCACACCGA-3') of the coding sequence (data not shown). The products unequivocally locate the transciptional start point on the A nucleotide at only 1 S bases upstream of the putative ATG (Fig 1 ). Other pollen-specific genes have been found to have long S'-untranslated sequences (SJ Tebbutt et al.., Plant Mol. Biol.
(1994) 25: 283-299). Thus this region of ZmCSg appears to be unusually short.
The calculated free energy for this short 5' UTL is of 0.9kJ/mol(M. Zuker, Meths.
Enzymol.
(1989) 180: 262-288) making it unlikely that it is able to form any stable secondary structure.
An open reading frame of 1692 by was identified and the putative ATG start codon (Figure 1) fits well with the consensus sequences (HA Lutcke et al.., EMBO J
6: (1987) 43 48). A putative TATAA motif (CP Joshi, Nucl. Acids Res. 15:6648-6653 (1987)) starts at t 5 32, however no recognisable CAAAT motif is found in the 60 by upstream from the transciptional start (Fig. 1 ) as has been found in many other plant genes.
ZmCSc lacks a clearly recognisable AATAAA polyadenylation site signal. This is not unusual:
30% of plant genes lack a recognisable AATAAA motif (BD Mogen et al.., Plant Cell 2 (1990) 1261-1272). In ZmCSc, a stretch of five A residues 16 by upstream from the poly A addition 2o site may be acting as a polyadenylation signal, although other pollen specific transcripts have been found to have longer than average distances between the AATAAA motif and the poly(A)+ addition site (Tebbutt et aL ., supra.) 25 Deduced amino-acid sequence of ZmCS
The predicted amino acid sequence of ZmCS (563 amino acids) was compared to the EMBL and GenBank databases, and revealed a high degree of homology to both plant (between 30.9% and 41.4%) and microbial PMEs (between 18.6% and 20.8%}. An alignment of amino acid sequences showed conservation across both plant and microbial 3o sequences restricted primarily to the C-terminal end of the protein which includes four regions likely to be the catalytic domains or active sites of the enzyme (D.
Albani et al.., Plant Mol Biol (1991) 16:501-513),0 Marcovic et al.., Protein Sci 1: 1288-1292 (1992)). In vitro mutagenesis of the A. niger PME (B Duwe et al.., Biotechnol. Lefts 18:
(1996)) indicated that a histidine residue, which is conserved in ZmCS, within the region I
may be located at the active site of the enzyme, and in A. niger is required for enzyme activity. However this histidine is replaced by other amino acid residues in several PMEs of both plant and fungal origin, suggesting that is it not essential in all PMEs.
In a comparison of the plant PMEs, ZmCS shows a closer relationship to the P. in, flata 'late' pollen expressed PPE gene (JH Mu et al.., Plant Mol Biol 25: 539-544 (1994)), than to B. napuS
'early' pollen expressed Bp 19 gene (D. Albani et al. . supra.) f0 Estimation of ZmCS Gene number A maize (inbred line A188) genomic Southern blot containing lSp,g of DNA
digested with either BamHI, EcoRI, or Hind III was probed with radiolabelled full-Length ZmCS
cDNA insert. Two strong hybridising bands in each lane of the blot in Figure 2 suggests the presence of at least two similar genes in the maize genome. Several further bands with show a much weaker signal suggests that this gene family may also comprise several less related members.
2o EXAMPLE 4 Spatial and temporal expression of ZmCS
A northern blot containing lOp,g total RNA from eight maize tissues was probed with the cDNA ZmCSc to determine the expression programme of the gene. A transcript of approximately 2.Okb was detected only in pollen and germinating pollen (Figure 3(A)) , indicating that, within the limits of detection of this technique, expression of this gene appears to be restricted to these two tissues. No signal was detectable in leaf, root, shoot, cob, endosperm or embryo. The expression programme during spikelet development was also determined. Figure 3(B) shows a Northern blot containing total RNA from 0.25, 0.5 and 1.Ocm spikelets, mature pollen and germinating pollen. The ethidium bromide stained gels 3o demonstrate the equal loadings of RNA in the lanes of each gel.
Spikelets were staged by staining the anthers with acto-carmine, and the anthers were found to contain cells at the following stages: pre-meitotic sporpogenous cells (0.25cm), mid-prophase I (0.5 cm), maturing pollen grains ( 1.0 cm). Some overlap between consecutive stages is however inevitable due to the variation in the developmental stage between the two florets within the same spikelet. This Northern analysis shows that ZmCS
expression is restricted to mature dehisced pollen and germinating pollen with no detectable expression in any other maize tissues including spikelets containing cells in earlier stages of microsporogenesis.
io EXAMPLE 5 Expression of ZmCS promoter/GUS constructs in transgenic plants Transciptional fusions were made between the 5' region of ZmCSg and the reporter gene (3-glucuronidase (Figure 4A), and used to transform tobacco by Agrobacterium transformation. The construct was made as follows:- the two Sph I sites, one within the 15 2.Skb SaII fragment which contains 2kb of 5'sequence relative to the ATG on one within the polylinker, were used to remove the 3' end from position -61 to +403 (Figure 1 ). This was directly replaced by and Sph I digested PCR fragment that included the region -61 to +1, additional restriction sites positioned at the 3' end (Bam HI, Hind III, Sal I) and a mutation to remove the Hind III site positioned at the transcriptional start (Figures 1 and 4A). The 20 original 5' Sal I site and the introduced 3'Sal I site were then used to excise the ZmCS
promoter region which was cloned into the Sma I site of pGUS. The ZmCS
promoter-UID-A
transcriptional fusion was then transferred to pain 19 vector (Figure 4A) and used for Agrobacterium-mediated leaf disc transformation of Nicotiana tabacum var Samsun.
Transformants were selected on kanamycin and primary transgenic plants were regenerated, 25 two of which, positive for expression of the transgene, were taken to the T2 generation.
Pollen grains from dehisced anthers of the transgenic plants were harvested and stained for GUS activity as described by J.A. Jefferson (Plant Mol Biol Rep (1987) 5: 387-405). Two plants were positive showing approximately SO% blue staining pollen (Figure 4B). No blue colouration was detected in non-transgenic controls. To investigate the 3o number of integration sites, plants from two transgenic lines were selfed, and progeny were scored for resistance to kanamycin. Of the progeny assessed from transgenic plant GCS-2, _ 17-303 were kanamycin resistant and 8 kanamycin sensitive giving a mean ratio of 38:1 indicative of at least two integration sites. The progeny of transgenic plant GCS-7 gave a mean ratio of kanamycin resistant to kanamycin sensitive of 3.8:1 indicative of a single integration site (expected ratio for one integration site is 3:1, for two, 15:1 and for three 63:1}.
Extracts were made from a range of tissues including five stages of developing anthers, and analysed fluorimetrically fir GUS expression (Jefferson. supra.) Figure 4(C) shows GUS activities from two transgenic plants. Only very low levels of expression are detectable in tissues other than developing and mature dehisced anthers. In tobacco the stage l0 of bud development can be correlated with bud length (Tebutt et al.., supra.} but this is dependent on the growth conditions. Thus Bud-1 corresponds to microspores at mitosis/tetrad stage; Bud-2, uninucleate microspores, Bud-3 microspore mitosis, Bud-4, early to mid-stage binucleate gametophyte, Bud-5 mid- to late-stage binucleate gamteophyte.
Microspore stages as assessed by DAPI staining (data not shown) indicate that the timing of expression of the ZmCS promoter in tobacco agrees well with its expression in maize based on the Northern data (Figure3; Figure 4C). Thus both in it native environment in maize and in transgenic tobacco, the ZmCS promoter function late in pollen development and is virtually inactive before microspore mitosis. Some variation in expression can be noted between the two transgenic lines with the GCS-2 showing higher levels of expression in 2o most tissues tested. Variation in expression levels are commonly found in transgenic populations and have been ascribed to the site of insertion of the transgene 9SLA Hobbs et al.., Plant Mol Biol 21: 17-26 (1993)).
Expression of GUS in pollen driven by AIcA Inducible Promoter A plant transformation vector comprising the Alc A promoter driving expression of GUS and a 35S CaMV promoter driving the expression of AIcR has been introduced into tobacco and tomato plants. GUS expression may be studied in all tissues before and after induction with ethanol as a root drench.
3o GUS staining of tomato anthers and pollen shows clear expression of GUS
after induction. The same result is expected from pollen from other species.
Preparation of CS-barnase Cassette - a dominant gametophytic male sterility cassette.
The unique SaII site of pBluescipt SK+ (Stratagene) was replaced with a NotI
recognition site by insertion of the an oligonucleotide linker MKLINK4 (5'-TCGATTCGGCGGCCGCCGAA-3'} into the digested SaII site. A 0.9kb, BamHI-HindIII
fragment carrying the coding region of barnase followed by a bacterial-promoter-driven barstar coding region, was inserted into the corresponding fragment of the modified pBluescript. The nos terminator on a HindIII- NotI fragment was inserted into the 1o corresponding fragment of the resulting vector. An unwanted BamHI site was then removed using Stratagene's QuickChange system, following the manufacturer's instructions and using oIigonucleotides DAM-3A (5'-GGTCGACTCTAGAGGAACCCCGGGTACCAAGC-3') and DAM-3S (S'- GCTTGGTACCCGGGGTTCCTCTAGAGTCGACC-3'). The resulting plasmid (named pSK-BBN) was digested to completion with BamHI, dephosphorylated with is shrimp alkaline phophatase (37°C, 1 hour). A l.9kb BamHI fragment of the CS 5' flanking region was Iigated into this, followed by digestion with BamHI and PstI to check for presence and orientation of the insert, respectively. The resulting plasmid was named pSK-CS-BBN (Figure 6). The entire cassette is then removed as an EcoRl- Notl fragment to a binary plant transformation vector pVB6. The construct is then introduced into 2o Agrobacterium Tumefaciens by the freeze-thaw method. Standard techniques are used to introduce the DNA into tobacco.
Analysis of sterile transgenic plants 25 Primary transformants are selected by growth on kanamycin in tissue culture and this confirmed by PCR analysis. The plants are grown to maturity in the glass house . Pollen is collected from anthers after dehiscence and a vital stain is used to establish whether the pollen is fertile or sterile. 50% of the pollen is expected to be sterile.
Backcrossing these plants with wild type plants (after anther removal) or allowing self pollination to occur 3o results in progeny in which 50% of pollen is sterile.
Other modifications to the present invention will be apparent to those skilled in the art without departing from the scope of the invention.
The present invention relates to a promoter sequence which is specific for pollen, to constructs and transgenic plant cells and plants comprising the promoter as well as to methods of transforming pollen and controlling fertility in plants using this promoter.
In order to introduce desirable genetic traits from two plants into a single plant, such as a variety or hybrid, cross-breeding represents the traditional approach. In order to reliably obtain consistent hybrids, it is necessary to ensure that the self pollination of the parent plants does not take place.
1o This can be achieved by ensuring that one of the parent lines is male sterile. Various techniques for producing male sterility are known and have been proposed in the art. One method involves removal of the anthers or tassels of the female parent plant, either manually or mechanically. This plant may then only be fertilised by pollen from the male parent and therefore its progeny will be hybrid. However, such a process is labour intensive and not 1 s altogether reliable as it is possible that some female plants may miss the detasseling process or in some cases, the plants develop secondary tassels after detasseling has been completed.
In addition in this system the male parent is able to self pollinate so it is necessary to physically separate male and female parents to allow ease of harvest of hybrid seed. This block planting works well for corn as the pollen is light and produced in large quantity.
2o However, this approach is not applicable to species with heavier pollen and in species in which the male and female floral organs are contained within one flower e.g.
wheat, rice.
Chemical methods of preventing pollen production are also known. US Patent No.
4,801,326 describes chemicals which may be applied to the plant or soil to prevent pollen production. However, again such techniques are labour intensive and are not wholly 2s reliable. It is essential that sufficient chemical is applied at the appropriate time intervals to ensure pollination does not occur, with the concomitant burden on the environment. In addition, these chemicals are very expensive.
Genetic engineering has provided an alternative way by which male sterility can be produced, maintained and/or subsequently restored in plants.
3o Systems have been described in which inducible promoters which allow fertility to be switched on or off depending upon the application or availability of an external compound.
_7_ For example, WO 90/08830 describes the induction of male sterility in a plant by a cascade of gene sequences which express a protein which disrupts pollen biosynthesis.
WO
93/18171 describes the use of a GST promoter to inducibly express chalcone synthase (chs) and restore fertility to a male sterile plant made sterile by "knocking out"
the endogenous chs genes.
A different approach was described in W093/25695 (PGS). This relies upon the use of a tapetum specific promoter to express a pollen lethality gene, barnase, in the tapetal cells which are critical to pollen development thus disrupting pollen production. A
restorer gene, barstar, can be used to restore fertility (Mariani et al. Nature Vol 357: 384-387).
There would be advantages to expressing genes which have an impact in pollen production in pollen directly in a controllable manner. Suitably, fertility should be restorable when desired.
A component of a system to genetically engineer male sterility is the availability of a promoter which specifically drives expression either in pollen or in tissue on which pollen production or development depends.
Many of the characterised genes which are specifically or highly expressed in pollen and germinating pollen encode proteins that are likely to play a role in cell wall metabolism, for example, those having homology to genes encoding enzymes involved in pectin degradation; polygalacturonases (SM Brown et al.., Plant Cell (1990) 2: 263-274, SJ Tebbutt 2o et al.., Plant Mol. Biol. (1994) 25:283-299), pectate lyase (HJ Rogers et al.:, Plant Mol Biol 20:493-502 (1992), RA Wing et al., Plant Mol Biol 14:17-28 (1989)) and pectin methylesterase (PME) JH Mu et al.., Plant Mol Biol 25:539-544 (1994)).
Other genes highly expresed in pollen include those that encode cytoskeletal proteins (I. Lopez et al.., Proc. Natl, Acad Sci USA 93: 7415-7420 (1996), HJ Rogers et al.., Plant J.
4: 875-882 (1993) and CJ Staiger et al.., Plant J. 4: 631-641 (1993)), putative ascorbate oxidases, a Kunitz protein inhibitor and many others whose function cannot be inferred by homology to known genes. The temporal expression of such genes has been studied and many are found to be expressed late in microsporogenesis reaching a maximum in mature microsporocytes. In some cases continued expression in the pollen tube has also been 3o demonstrated (AK Kononowicz et al.., Plant Cell 4; 513-524 ( 1992)). These genes are referred to as "late genes". The majority of expression at this stage is from the vegetative cell rather than from the generative cell and it is likely that the majority of these 'late' genes are transcribed from the vegetative nucleus; although this has only been demonstrated for one "late" gene (D. Twell, Plant J2: 887-892 (1992). A distinct class of genes expressed in anthers is found to have a different expression programme, being first detectable soon after the tetrad stage and declining in expression well before pollen maturity. It is likely that the major role of these 'early' genes may be during microspore differentiation and development rather than pollen tube growth. In addition, US Patent No. 5.086,169 (Mascarenhas) describes the isolation of the frst pollen-specific promoter from com.
The applicants have isolated a further promoter which is specifically expressed only in pollen tissue. The promoter is derived from a 'late' pollen expressed gene isolated from maize, ZmCS.
Thus, according to a first aspect of the present invention there is provided a recombinant nucleic acid sequence which comprises a promoter sequence of the ZmCS gene in maize, or a variant or fragment thereof, which acts as a promoter in pollen.
t5 As used herein, the term "fragment" includes one or more regions of the basic sequence which retain promoter activity. Where the fragments comprise one or more regions, they may be joined together directly or they may be spaced apart by additional bases.
The expression "variant" with reference to the present invention means any 2o substitution of, variation of, modification of, replacement of, deletion of or the addition of one or more nucleotides from or to the nucleic acid sequence providing the resultant sequence exhibits pollen promoter expression. The term also includes sequence that can substantially hybridise to the nucleic acid sequence.
As used herein, the expression "ZmCS gene" refers to the gene of maize which 25 encodes a 563 amino acid sequence as described herein. A cDNA sequence encoding this sequence is defined in EMBL Y13285 The promoter sequence of the present invention is comprised within the clone deposited National Collection of Industrial and Marine Bacteria as NCIMB 40915 on 26 Jan 1998. This is a Sal I fragment derived as described hereinafter. The promoter region lies 3o within a region which consists of approximately 2kb of sequence upstream of the transcription start site of the ZmCS gene of maize as shown in Figure 1 hereinafter.
WO 99/42587 - ~ PCT/GB99/00232 According to a preferred embodiment of the present invention, there is provided a recombinant nucleic acid sequence which comprises a promoter sequence comprising at least part of the DNA sequence as shown in Figure 5 or at least part of a sequence encoding a promoter which has substantially similar activity to the promoter encoded by Figure 5 or a variant or fragment thereof.
The term "substantially similar activity" includes DNA sequences which are complementary to and hybridise to the DNA of the present invention and which code for a promoter which acts in pollen. Preferably, such hybridisation occurs at, or between, low and high stringency conditions. In general terms, low stringency conditions can be defined as 3 x 1o SCC at ambient temperature of between about 60°C to about 65°C, and high stringency conditions as 0.1 x SSC at about 65°C. SSC is the name of a buffer of O.15M NaCI, 0.01 SM
trisodium citrate. 3 x SSC is three times as strong as SSC and so on.
The pollen specific promoter of the present invention may be used to engineer male sterility by driving genes capable of interfering with pollen production or viability, or to 15 express genes of interest specifically in pollen grains.
According to a second aspect of the present invention, the promoter sequence may form part of an expression cassette in combination with genes whose expression in pollen, and particularly in late pollen production, may be desirable. These include genes which have an impact on pollen or pollen production. Such genes may be those involved in the control 20 of male-fertility, genes which encode insecticidal toxins (which would then be targeted to insect species which feed on pollen), or genes which would enhance or modify the nutritional value of the pollen. In addition, the promoter sequence could be used to drive expression of a selectable marker for use in pollen transformation. Examples of suitable selectable marker genes include antibiotic resistance genes such as kanamycin resistance gene, hygromycin 25 resistance gene and the PAT resistance gene so as to enable stable transformants to be identified depending on the species e.g. corn, rice, wheat.
The term "expression cassette" - which is synonymous with terms such as "DNA
construct", "hybrid" and "conjugate" - includes an effect gene directly or indirectly attached to the regulator promoter, such as to form a cassette. An example of an indirect attachment is 3o the provision of a suitable spacer group such as an intron sequence intermediate the promoter and the target gene. The DNA sequences may furthermore be on different vectors and are therefore not necessarily located on the same vector. The same is true for the term "fused" in relation to the present invention which includes direct or indirect attachment. Such constructs also include plasmids and phage which are suitable for transforming a cell of interest.
According to a preferred embodiment, expression cassettes of the present invention comprise a promoter sequence as described above which is arranged to control expression of a gene which is deleterious to pollen development, such as genes encoding barnase, adenine nucleotide translocator, mutant tubulins, T-urf (as claimed in WO 97/04116) or trehalose phosphate phosphatase (TPP).
1o For instance, W093/25695 describes the use of the gene barnase which encodes a cytotoxic protein , which is under the control of a tapetum specific promoter.
Expression of barnase in the tapetal cells disrupts these cells and leads to disruption of pollen production.
Ribozymes are RNA molecules capable of catalysing endonucleolytic cleavage reactions. They can catalyse reactions in trans and can be targeted to different sequences.
15 They are therefore potential alternatives to antisense as a means of modulating gene expression. (Hasselhof and Gerlach (1988) Nature Vol 334: 585-591) or Wegener et al.
(1994) Mol Gen Genet 245: (465-470) have demonstrated the generation of a trans -dominant mutation by expression of a ribozyme gene in plants. If required, the pollen specific promoter of the present invention may be used to control expression of the ribozymes such 2o that they are specifically expressed in pollen.
Baulcombe (1997) describes a method of gene silencing in transgenic plants via the use of replicable viral RNA vectors (AmpliconsT"') which may also be useful as a means of knocking out expression of endogenous genes. This method has the advantage that it produces a dominant mutation i.e. is scorable in the heterozygous state and knocks out all 25 copies of a targeted gene and may also knock out isoforms. This is a clear advantage in wheat which is hexaploid. Fertility could then be restored by using an inducible promoter to drive the expression of a functional copy of the knocked out gene. By including the pollen specific promoter as the elements of the AmpliconT"" vector, expression of the gene would then take place specifically in the pollen.
3o The use of cytotoxic or disrupter genes as means of disrupting pollen production requires the expression of restorer genes to regain fertility. Suitably the construct further comprises a cassette comprising a nucleotide sequence which is able to overcome the effect of said deleterious gene, such as a restorer gene such as barstar in the case of barnase or TPS
in the case of TPP, or a sequence which encodes a construct which is sense or antisense to a deleterious gene.
An alternative means of controlling expression of deleterious genes is to use operator sequences. Operator sequences such as lac, tet, 434 etc. may be inserted into promoter regions as described in WO 90/08830. Repressor molecules can then bind to these operator sequences and prevent transcription of the downstream gene, for example a gene deleterious to pollen development (Wilde et al. ( 1992) EMBO J. 11, 1251 ). Furthermore, it is possible to 1 o engineer operator sequences with enhanced binding capacity such as the Lac IO His mutant as described in (Lehming et al. (1987) EMBO . 6, 3145-3153). This has a change of amino acid from tyrosine to histidine at position 17 thus giving tight control of expression. Used in combination with inducible expression of the repressor this then allows expression of an inactivating gene to be turned off.
15 In this way, the expression cassettes may be incorporated into expression systems which may be used in the control of fertility of a plant as described above.
The term "expression system" means that the system defined above can be expressed in an appropriate organism, tissue, cell or medium. The system may comprise one or more expression cassettes and may also comprise additional components that ensure to increase 2o expression of the target gene by use of the regulator promoter.
According to a third aspect of the present invention, there is provided an expression system comprising (a) a first promoter sequence which is expressed specifically in pollen;
(b) a first gene which, when expressed, disrupts pollen biogenesis. under the control of said 25 pollen specific promoter;
(c) a second promoter sequence responsive to the presence or absence of an exogenous chemical inducer; and (d) a second gene encoding an element which can inhibit either expression of said first gene, or can inhibit the protein coded for by said f rst gene, operably linked to and under the 3o control of said second promoter sequence.
_'7_ Elements (a) and (b) and (c) and (d) above may be provided by one or two individual vectors, but preferably are contained in the same vector to ensure co-segregation. These can be used to transform or co-transform plant cells so as to allow the appropriate interaction between the elements to take place.
The second promoter sequence and the second gene provide for chemical "switching" on and off of the first gene. Where the second promoter sequence is responsive to the presence of the exogenous chemical inducer, application of the chemical inducer to pollen or to a plant will have the effect of switching on the second gene which thereby counteracts the effect of the first gene. The absence of the chemical inducer will have a 1 o similar effect where the second promoter sequence is active only in the absence of the chemical inducer.
Elements (c) and (d) are suitably in the form of an expression cassette comprising a nucleotide sequence which is able to overcome the effect of said deleterious gene, such as a restorer gene such as barstar in the case of barnase or TPS in the case of TPP, or a sequence 15 which encodes a construct which is sense or antisense to a deleterious gene, or a gene encoding a repressor molecule in the case of operator sequences being used operatively interconnected with an inducible promoter.
The expression system of the present invention may further comprise a selectable marker, such as herbicide resistance genes or antibiotic resistance genes so as to allow stable 2o transformants to be identified depending on the species eg corn, rice, wheat. The presence of a herbicide resistance gene also allows selection of male sterile progeny in a segregating population.
Transformation of a plant with such an expression system will result in the production of male sterile plants and methods of producing such a plant form a fourth aspect 25 of the present invention.
Expression systems in accordance with this embodiment of the present invention, wherein the gene is deleterious to viable pollen production, are useful in the production of hybrids but are especially useful when the male sterile line can be made homozygous. When "late" promoters, such as the ZmCS promoter described above, are used, because the gene 3o products are expressed late in pollen development, primary transformants and heterozygotes _g_ produce pollen which segregates I :1 for sterility i.e. 50% of the pollen is fertile and so self pollination leading to non-hybrid seed may occur.
In order to obtain a homozygous sterile plant, the inducible promoter must be switched on to drive expression of the restorer gene using the appropriate chemical such as ethanol in the case of the AIcAlR switch or safener for the GST switch. This then inactivates the deleterious gene, so allowing self pollination to occur in accordance with the model below.
MS = Dominant male sterility 1 o Rcs = inducible restorer Heterozygous genotype MSRcs---Gametes MSRcs ---~ 5 Self pollination after chemical induction gives MSRcs ---MSRcs MSMSRcsRcs ---MSRcs --- MSRcs--- --- ---All pollen from the homozygous progeny (MSMSRcsRcs) will be sterile. 50% of the pollen from the heterozygous progeny (MSRcs---) will be sterile. All of the pollen from the null (--- ---) progeny will be fertile. Staining of the pollen from these lines with a vital stain such as DAPI will allow identification of the plant producing 100% sterile pollen.
Alternatively, the induction and self pollination can be repeated on this segregating population and the progeny analysed for segregation of sterility. Clearly all progeny deriving from self pollination of the homozygous line will themselves be homozygous and male 3o sterile i.e. they will all produce 100% sterile pollen, whereas progeny arising from self pollination of a heterozygous line will continue to segregate for sterility.
Alternatively, if the WO 99/42587 _ 9 _ PCT/GB99/00232 gene giving rise to male sterility is linked to a gene conferring herbicide resistance, then progeny may be sprayed with herbicide at an early seedling stage, herbicide tolerance will segregate with the sterility gene. In this way, male sterile parents can be identified and selected for hybrid production.
Once identified, this homozygous sterile line may be used in the production of F I
hybrids by cross pollination by an unmodified inbred male parent line. See below.
Female parent Male parent MSMSRcsRcs *** ***
to Gametes MSRcs MSRcs MSRcs *** MSRcs*** MSRcs***
Fl *** MSRcs*** MSRcs***
Thus, all the F 1 seed is hybrid and heterozygous for sterility, meaning that 50% of the 2o pollen from each plant is fertile. In a crop species such as corn this is ample viable pollen to ensure complete pollination across a field due to the sheer volume of pollen produced by each tassel. In wheat too this should be sufficient pollen to ensure no yield loss as self pollination occurs while the flower is still closed, thus reducing loss by wind etc. In species in which the vegetative part of the plant is harvested then reduced pollen viability is not a factor to be taken into account.
There is too an additional benefit to the hybrid seed producer in that should the farmer retain F2 seed for subsequent planting he will suffer a loss in yield as result of loss of heterosis. See below.
WO 99/42587 _ 1 O _ PCT/GB99/00232 F 1 MSRcs***
Gametes MSRcs (not viable) MSRcs none * * * MSRcs *** none *** ***
These methods may allow for reversal of the sterility, for example in hybrid production, by activation using an inducible promoter.
According to a fifth aspect of the present invention, there is provided a method of 1o controlling the fertility of a plant which comprises transforming said plant with an expression system as described above, and when fertility is to be restored, activating the inducible promoter.
Suitable inducible promoters include those which are controlled by the application of an external chemical stimulus, such a herbicide safener. Examples of inducible promoters t5 include, for example, a two component system such as the alcAlalcR gene switch promoter system described in our published International Publication No. WO 93/21334, the ecdysone switch system as described in our International Publication No. WO 96/37609 or the GST
promoter as described in published International Patent Application Nos. WO
90/08826 and WO 93/031294, the teachings of which are incorporated herein by reference.
Such promoter 2o systems are herein referred to as "switch promoters". The switch chemicals used in conjunction with the switch promoters are agriculturally acceptable chemicals making this system particularly useful in the method of the present invention.
If the pollen specific promoter of the present invention is used to obtain male sterility, full restoration of fertility may not be achievable by this method as pollen is haploid. This 25 means that only 50% of pollen produced following activation of the restorer gene is fertile.
This may be countered by the fact that expression using the promoter of the present invention is highly tissue specific.
This property makes the use of the promoter of the present invention particularly useful in some very particular applications. For example, in some cases transformation of 3o pollen is required. In this instance the use of the pollen specific promoter be may highly desirable. An example of such an application is known as MAGE LITER (male germ line transformation) and is described by Stoger et al. (Plant Cell Reports 14 (1995) 273-278). In this method, pollen is transformed by microprojectile bombardment. A pollen specific promoter is used to drive, for example a selectable marker gene. The fact that the promoter is pollen specific confers several advantages. First of all, the marker is expressed only in the pollen, not the rest of the plant and so the remaining plant tissue does not contain unwanted marker. Furthermore, having a selectable marker only in the pollen allows the possibility of retransforming by the usual methods and not having to have a different selectable marker, i.e.
it allows easier gene stacking. The reasons why pollen transformation is important are that pollen can be made to undergo sporophytic development i.e. will give rise to haploid and t o doubled haploid plants. This means that homozygosity is achieved in one step.
Alternatively, the transformed pollen can be used to pollinate wildtype plants thus giving seed carrying the introduced transgene, again a faster process than the traditional transformation route.
The expression systems of the present invention can be introduced into a plant or t s plant cell via any of the available methods including infection by Agrobacterium tumefaciens containing recombinant Ti plasmids, electroporation, microinjection of plant cells and protoplasts, microprojectile bombardment, bacterial bombardment, particularly the "fibre" or "whisker" method, and pollen tube transformation, depending upon the particular plant species being transformed. 'The transformed cells may then in suitable cases be 2o regenerated into whole plants in which the new nuclear material is stably incorporated into the genome. Both transformed monocot and dicot plants may be obtained in this way.
Reference may be made to the literature for full details of the known methods.
Such methods form a further aspect of the present invention.
The method of the present invention would be useful in the production of a wide 25 range of hybrid plants, such as wheat, rice, corn, cotton, sunflower, sugar beet, and lettuce, oil seed rape and tomato.
Plant cells which contain a plant gene expression system as described above, together with plants comprising these cells form further aspects of the invention.
According to a nineth aspect of the present invention there is provided a replicable 3o viral DNA vector (AmpliconT"") which comprises a recombinant nucleic acid as defined above.
According to a tenth aspect of the present invention, there is provided a method of transforming pollen cells with an expression system as described above.
The invention will now be particularly described only by way of example with reference to the accompanying drawings in which:-Figure 1 is a diagram showing the alignment of the ZmCS cDNA with a 2.4kb fragment from the 5'region of its corresponding gene. The transcriptional start point is indicated (*), and the putative translational start is underlined. Sa= Sal I, S=Sma I, Sp= Sph I, H = Hind III, X =
Xho I, P = Pst I;
to Figure 2 shows a Southern blot of maize (inbred line A188) genomic DNA. Each lane contains l5pg of genomic DNA digested in lane 1 with Eco RI, in lane 2 with Hind III, and in lane 3 with Bam HI. The Southern blot was hybridised with radiolabelled ZmCS cDNA
probe.
t5 Figure 3 shows ethidium bromide stained gels showing the 18S RNAs of various maize tissue total RNAs and the northern blots of the same gels probed with the ZmCS
cDNA
probe.
(A) the gel was loaded with 10~g of total RNA from various maize tissues.
20 (B) the gel was loaded with l Opg of total RNA isolated from shoot, a developmental staged series of spikelets, pollen and germinating pollen.
Figure 4 shows (A) Physical map of the ZmCS::uidA construct and junction sequence. The A
residues by *, 25 t and ~ correspond to the ZmCS transcription start point, the T to A
mutation to remove the Hind III site (for ease of cloning) and the 3' terminus of the ZmCS promoter region, respectively. The uidA translation start is underlined.
(B) Histochemical analysis of GUS activity in pollen from transgenic ZmCS::uidA tobacco 3o showing segregation of the blue staining.
WO 99/42587 PC1'/GB99/00232 (C) Promoter activity of ZmCS in transgenic tobacco tissues from two transgenic lines, GCS-2( unfilled columns) and GCS-7 (filled columns). Data from each line represents the mean from two independent assays, normalised to a non-transgenic control. Bud stages are as follows: Bud-1 corresponds to buds of 5-8mm, (microspores at meiosis/tetrad stage), Bud-2: buds of 10-l2mm (uninucleate microspores), Bud-3: 13-lSmm, (microspore mitosis), Bud-4: (17-22mm) early- to mid-stage binucleate gametophyte, Bud-5: (27-45mm) mit- to late stage binucleate gametophyte (Tebbutt et al.., supra.).
Figure 5 shows the DNA sequence encoding the ZmCS promoter sequence in maize.
1o The underlined A is the putative transcriptional start point and the bold and underlined ATG
is the translational start point.
Figure 6 shows an expression cassette comprising CS-barnase/barstar-nos.
15 ZmCS cDNA and genomic clones Maize (inbred line A188) pollen and germinating pollen (HJ Rogers et al.., Plant J4 (1993) 875-882) cDNA libraries were screened using cDNA probes made to pollen and shoot poly(A)+ RNA following standard procedures (FM Ausubel et al.., Current protocols in Molecular Biology, Wiley, New York (1990)). All clones, totalling 1,101, that showed 2o hybridisation to the radiolabelled pollen cDNA but not to the radiolabelled shoot DNA were picked. Random colonies were picked and sequenced at the 5' end and the sequence compared on current databases. One clone which had an insert of 800bp showed significant sequence identity with known pectin methyl esterases. The pollen cDNA library was re-screened with this cDNA insert and the full length ZmCS clone (ZmCSc) was identified and 25 sequenced.
A maize (inbred line B73) genomic library (8x106 plaques) was screened using a PCR
fragment corresponding to the 5' 270bp of cDNA clone ZmCSc labelled by random priming (Ausubel et al.., supra). One positive clone ZmCSg was plaque purified.
Comparison of the sequence of a 2.Skb SaII fragment of ZmCSg subcloned into pUCl9 with ZmCSc (and 3o deposited as NCIMB 40915) showed that the two sequences overlapped and that they were identical, indicating that the clones represent the same gene. A
representation of the overlap between the 2.Skb fragment of the genomic clone with the cDNA is shown in Figure I .
A transcriptional start point was mapped using two oligonucleotide primers complementary to nucleotides I to 21 (5'- ACCTAGGAGAGCCTTTGCCAT-3') and 56 to 82 (5'-AGCGGGTGACGGTGGCGACCACACCGA-3') of the coding sequence (data not shown). The products unequivocally locate the transciptional start point on the A nucleotide at only 1 S bases upstream of the putative ATG (Fig 1 ). Other pollen-specific genes have been found to have long S'-untranslated sequences (SJ Tebbutt et al.., Plant Mol. Biol.
(1994) 25: 283-299). Thus this region of ZmCSg appears to be unusually short.
The calculated free energy for this short 5' UTL is of 0.9kJ/mol(M. Zuker, Meths.
Enzymol.
(1989) 180: 262-288) making it unlikely that it is able to form any stable secondary structure.
An open reading frame of 1692 by was identified and the putative ATG start codon (Figure 1) fits well with the consensus sequences (HA Lutcke et al.., EMBO J
6: (1987) 43 48). A putative TATAA motif (CP Joshi, Nucl. Acids Res. 15:6648-6653 (1987)) starts at t 5 32, however no recognisable CAAAT motif is found in the 60 by upstream from the transciptional start (Fig. 1 ) as has been found in many other plant genes.
ZmCSc lacks a clearly recognisable AATAAA polyadenylation site signal. This is not unusual:
30% of plant genes lack a recognisable AATAAA motif (BD Mogen et al.., Plant Cell 2 (1990) 1261-1272). In ZmCSc, a stretch of five A residues 16 by upstream from the poly A addition 2o site may be acting as a polyadenylation signal, although other pollen specific transcripts have been found to have longer than average distances between the AATAAA motif and the poly(A)+ addition site (Tebbutt et aL ., supra.) 25 Deduced amino-acid sequence of ZmCS
The predicted amino acid sequence of ZmCS (563 amino acids) was compared to the EMBL and GenBank databases, and revealed a high degree of homology to both plant (between 30.9% and 41.4%) and microbial PMEs (between 18.6% and 20.8%}. An alignment of amino acid sequences showed conservation across both plant and microbial 3o sequences restricted primarily to the C-terminal end of the protein which includes four regions likely to be the catalytic domains or active sites of the enzyme (D.
Albani et al.., Plant Mol Biol (1991) 16:501-513),0 Marcovic et al.., Protein Sci 1: 1288-1292 (1992)). In vitro mutagenesis of the A. niger PME (B Duwe et al.., Biotechnol. Lefts 18:
(1996)) indicated that a histidine residue, which is conserved in ZmCS, within the region I
may be located at the active site of the enzyme, and in A. niger is required for enzyme activity. However this histidine is replaced by other amino acid residues in several PMEs of both plant and fungal origin, suggesting that is it not essential in all PMEs.
In a comparison of the plant PMEs, ZmCS shows a closer relationship to the P. in, flata 'late' pollen expressed PPE gene (JH Mu et al.., Plant Mol Biol 25: 539-544 (1994)), than to B. napuS
'early' pollen expressed Bp 19 gene (D. Albani et al. . supra.) f0 Estimation of ZmCS Gene number A maize (inbred line A188) genomic Southern blot containing lSp,g of DNA
digested with either BamHI, EcoRI, or Hind III was probed with radiolabelled full-Length ZmCS
cDNA insert. Two strong hybridising bands in each lane of the blot in Figure 2 suggests the presence of at least two similar genes in the maize genome. Several further bands with show a much weaker signal suggests that this gene family may also comprise several less related members.
2o EXAMPLE 4 Spatial and temporal expression of ZmCS
A northern blot containing lOp,g total RNA from eight maize tissues was probed with the cDNA ZmCSc to determine the expression programme of the gene. A transcript of approximately 2.Okb was detected only in pollen and germinating pollen (Figure 3(A)) , indicating that, within the limits of detection of this technique, expression of this gene appears to be restricted to these two tissues. No signal was detectable in leaf, root, shoot, cob, endosperm or embryo. The expression programme during spikelet development was also determined. Figure 3(B) shows a Northern blot containing total RNA from 0.25, 0.5 and 1.Ocm spikelets, mature pollen and germinating pollen. The ethidium bromide stained gels 3o demonstrate the equal loadings of RNA in the lanes of each gel.
Spikelets were staged by staining the anthers with acto-carmine, and the anthers were found to contain cells at the following stages: pre-meitotic sporpogenous cells (0.25cm), mid-prophase I (0.5 cm), maturing pollen grains ( 1.0 cm). Some overlap between consecutive stages is however inevitable due to the variation in the developmental stage between the two florets within the same spikelet. This Northern analysis shows that ZmCS
expression is restricted to mature dehisced pollen and germinating pollen with no detectable expression in any other maize tissues including spikelets containing cells in earlier stages of microsporogenesis.
io EXAMPLE 5 Expression of ZmCS promoter/GUS constructs in transgenic plants Transciptional fusions were made between the 5' region of ZmCSg and the reporter gene (3-glucuronidase (Figure 4A), and used to transform tobacco by Agrobacterium transformation. The construct was made as follows:- the two Sph I sites, one within the 15 2.Skb SaII fragment which contains 2kb of 5'sequence relative to the ATG on one within the polylinker, were used to remove the 3' end from position -61 to +403 (Figure 1 ). This was directly replaced by and Sph I digested PCR fragment that included the region -61 to +1, additional restriction sites positioned at the 3' end (Bam HI, Hind III, Sal I) and a mutation to remove the Hind III site positioned at the transcriptional start (Figures 1 and 4A). The 20 original 5' Sal I site and the introduced 3'Sal I site were then used to excise the ZmCS
promoter region which was cloned into the Sma I site of pGUS. The ZmCS
promoter-UID-A
transcriptional fusion was then transferred to pain 19 vector (Figure 4A) and used for Agrobacterium-mediated leaf disc transformation of Nicotiana tabacum var Samsun.
Transformants were selected on kanamycin and primary transgenic plants were regenerated, 25 two of which, positive for expression of the transgene, were taken to the T2 generation.
Pollen grains from dehisced anthers of the transgenic plants were harvested and stained for GUS activity as described by J.A. Jefferson (Plant Mol Biol Rep (1987) 5: 387-405). Two plants were positive showing approximately SO% blue staining pollen (Figure 4B). No blue colouration was detected in non-transgenic controls. To investigate the 3o number of integration sites, plants from two transgenic lines were selfed, and progeny were scored for resistance to kanamycin. Of the progeny assessed from transgenic plant GCS-2, _ 17-303 were kanamycin resistant and 8 kanamycin sensitive giving a mean ratio of 38:1 indicative of at least two integration sites. The progeny of transgenic plant GCS-7 gave a mean ratio of kanamycin resistant to kanamycin sensitive of 3.8:1 indicative of a single integration site (expected ratio for one integration site is 3:1, for two, 15:1 and for three 63:1}.
Extracts were made from a range of tissues including five stages of developing anthers, and analysed fluorimetrically fir GUS expression (Jefferson. supra.) Figure 4(C) shows GUS activities from two transgenic plants. Only very low levels of expression are detectable in tissues other than developing and mature dehisced anthers. In tobacco the stage l0 of bud development can be correlated with bud length (Tebutt et al.., supra.} but this is dependent on the growth conditions. Thus Bud-1 corresponds to microspores at mitosis/tetrad stage; Bud-2, uninucleate microspores, Bud-3 microspore mitosis, Bud-4, early to mid-stage binucleate gametophyte, Bud-5 mid- to late-stage binucleate gamteophyte.
Microspore stages as assessed by DAPI staining (data not shown) indicate that the timing of expression of the ZmCS promoter in tobacco agrees well with its expression in maize based on the Northern data (Figure3; Figure 4C). Thus both in it native environment in maize and in transgenic tobacco, the ZmCS promoter function late in pollen development and is virtually inactive before microspore mitosis. Some variation in expression can be noted between the two transgenic lines with the GCS-2 showing higher levels of expression in 2o most tissues tested. Variation in expression levels are commonly found in transgenic populations and have been ascribed to the site of insertion of the transgene 9SLA Hobbs et al.., Plant Mol Biol 21: 17-26 (1993)).
Expression of GUS in pollen driven by AIcA Inducible Promoter A plant transformation vector comprising the Alc A promoter driving expression of GUS and a 35S CaMV promoter driving the expression of AIcR has been introduced into tobacco and tomato plants. GUS expression may be studied in all tissues before and after induction with ethanol as a root drench.
3o GUS staining of tomato anthers and pollen shows clear expression of GUS
after induction. The same result is expected from pollen from other species.
Preparation of CS-barnase Cassette - a dominant gametophytic male sterility cassette.
The unique SaII site of pBluescipt SK+ (Stratagene) was replaced with a NotI
recognition site by insertion of the an oligonucleotide linker MKLINK4 (5'-TCGATTCGGCGGCCGCCGAA-3'} into the digested SaII site. A 0.9kb, BamHI-HindIII
fragment carrying the coding region of barnase followed by a bacterial-promoter-driven barstar coding region, was inserted into the corresponding fragment of the modified pBluescript. The nos terminator on a HindIII- NotI fragment was inserted into the 1o corresponding fragment of the resulting vector. An unwanted BamHI site was then removed using Stratagene's QuickChange system, following the manufacturer's instructions and using oIigonucleotides DAM-3A (5'-GGTCGACTCTAGAGGAACCCCGGGTACCAAGC-3') and DAM-3S (S'- GCTTGGTACCCGGGGTTCCTCTAGAGTCGACC-3'). The resulting plasmid (named pSK-BBN) was digested to completion with BamHI, dephosphorylated with is shrimp alkaline phophatase (37°C, 1 hour). A l.9kb BamHI fragment of the CS 5' flanking region was Iigated into this, followed by digestion with BamHI and PstI to check for presence and orientation of the insert, respectively. The resulting plasmid was named pSK-CS-BBN (Figure 6). The entire cassette is then removed as an EcoRl- Notl fragment to a binary plant transformation vector pVB6. The construct is then introduced into 2o Agrobacterium Tumefaciens by the freeze-thaw method. Standard techniques are used to introduce the DNA into tobacco.
Analysis of sterile transgenic plants 25 Primary transformants are selected by growth on kanamycin in tissue culture and this confirmed by PCR analysis. The plants are grown to maturity in the glass house . Pollen is collected from anthers after dehiscence and a vital stain is used to establish whether the pollen is fertile or sterile. 50% of the pollen is expected to be sterile.
Backcrossing these plants with wild type plants (after anther removal) or allowing self pollination to occur 3o results in progeny in which 50% of pollen is sterile.
Other modifications to the present invention will be apparent to those skilled in the art without departing from the scope of the invention.
Claims (27)
- A recombinant nucleic acid sequence which comprises a promoter sequence of the ZmC5 gene in maize, or a variant or fragment thereof, which acts as a promoter in pollen.
- 2. A recombinant nucleic acid sequence according to claim 1 which comprises approximately 2kb upstream of the transcriptional start site of the ZmC5 gene of maize as shown in Figure 1.
- 3. A recombinant nucleic acid sequence according to claim 1 or claim 2 which comprises a promoter sequence comprising at least part of the DNA sequence as shown in Figure 5 or at least part of a sequence which encodes a promoter which has substantially similar activity to that shown in Figure 5, or a variant or fragment thereof.
- 4. An expression cassette comprising a nucleic acid sequence according to any one of claims 1 to 3 wherein the cassette is arranged to control a gene which it is desired to be expressed in pollen and which encodes a product capable of having an impact on pollen production, insecticidal toxins, or enhances or modifies the nutritional value of pollen.
- 5. An expression cassette according to claim 4 wherein said gene comprises a gene which is deleterious to pollen development.
- 6. An expression cassette according to claim 5 wherein said gene comprises a gene encoding either barnase, adenine nucleotide translocator, mutant tubulins, T-urf or trehalose phosphate phosphatase (TPP) or a ribozyme.
- 7. An expression cassette according to claim 4 wherein the said gene comprises a selectable marker gene.
- 8. An expression cassette according to claim 7 wherein the selectable marker gene comprises and antibiotic resistance gene.
- 9. An expression system comprising an expression cassette according to any one of claims 4 to 8.
- 10. An expression system according to claim 9 which comprises a gene which is deleterious to pollen, and which further comprises an expression cassette comprising a second nucleic acid sequence which encodes a peptide or protein able to overcome the effect of said deleterious gene, operatively interconnected with a chemical inducible promoter.
- 11. An expression system according to claim 10 wherein the said nucleic acid sequence comprises a restorer gene.
- 12. An expression system according to claim 11 wherein the said restorer gene is barstar or TPS.
- 13. An expression system according to claim 10 wherein said nucleic acid sequence encodes a construct which is sense or antisense to said deleterious gene so as to suppress expression thereof.
- 14. An expression system according to claim 10 wherein said second nucleic acid sequence encodes a repressor protein to lac, tet, 434, lac-His, which interacts with an operator sequence which is operably linked to the nucleic acid sequence of any one of claims 1 to 3, or an AmpliconTM, so as to prevent expression of the first gene which it is desired to be expressed in pollen.
- 15. An expression system according to any one of claims 10 to 14 wherein the inducible promoter is the AlcA/R, GST or Ecdysone inducible promoter.
- 16. An expression system according to any one of claims 9 to 15 which further comprises a selection marker.
- 17. An expression system according to any one of claims 9 to 16 wherein the gene which it is desired to be expressed in pollen is linked to a herbicide resistance gene.
- 18. An expression system comprising (a) a first promoter sequence which is expressed specifically in pollen;
(b) a first gene which when expressed, disrupts pollen biogenesis, under the control of said pollen specific promoter;
{c) a second promoter sequence responsive to the presence or absence of an exogenous chemical inducer; and (d) a second gene encoding an element which can inhibit either expression of said first gene, or can inhibit the said first protein, operably linked to and under the control of said second promoter sequence. - 19. A method of producing a plant which method comprises transforming a plant cell with an expression system according to any one of claims 9 to 18.
- 20. A plant cell which comprises an expression system according to any one of claims 9 to 18.
- 21. A plant which comprises cells according to claim 20.
- 22. A method of inducing male sterility in plants which method comprises transforming a plant with an expression system according to any one of claims 10 to 18.
- 23. A method of controlling the fertility of a plant which comprises transforming said plant with an expression system according to claim 11 or claim 18, and when fertility is required to be restored, activating the inducible promoter.
- 24. A method according to claim 23 wherein the inducible promoter is activated by application of a chemical to the plant.
- 25. A replicable viral RNA vector (AmpliconTM) which comprises a recombinant nucleic acid according to any one of claims 1 to 3.
- 26. A method of transforming pollen which comprises transforming pollen cells with an expression system according to claim 9 or claim 18.
- 27. A recombinant nucleic acid, an expression cassette, an expression system or a method substantially as hereinbefore described with reference to any one of the accompanying Figures.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9803661.9 | 1998-02-20 | ||
GB9803660.1 | 1998-02-20 | ||
GBGB9803660.1A GB9803660D0 (en) | 1998-02-20 | 1998-02-20 | Expression system |
GBGB9803661.9A GB9803661D0 (en) | 1998-02-20 | 1998-02-20 | Pollen specific promoter |
PCT/GB1999/000232 WO1999042587A1 (en) | 1998-02-20 | 1999-01-22 | Pollen specific promoter |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2319079A1 true CA2319079A1 (en) | 1999-08-26 |
Family
ID=26313163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002319079A Abandoned CA2319079A1 (en) | 1998-02-20 | 1999-01-22 | Pollen specific promoter |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1054970A1 (en) |
JP (1) | JP2002504335A (en) |
KR (1) | KR20010041129A (en) |
CN (1) | CN1301300A (en) |
AU (1) | AU751438B2 (en) |
BR (1) | BR9907997A (en) |
CA (1) | CA2319079A1 (en) |
DZ (1) | DZ2725A1 (en) |
HU (1) | HUP0100787A3 (en) |
IL (1) | IL137971A0 (en) |
WO (1) | WO1999042587A1 (en) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000053763A1 (en) * | 1999-03-08 | 2000-09-14 | Pioneer Hi-Bred International, Inc. | Maize metallothionein gene and promoter |
EP1404850B1 (en) | 2001-07-06 | 2011-10-26 | Monsanto Technology LLC | Methods for enhancing segregation of transgenes in plants and compositions thereof |
US7205454B2 (en) * | 2002-07-31 | 2007-04-17 | Bayer Bioscience N.V. | Corn root preferential promoters and uses thereof |
KR100537955B1 (en) * | 2003-10-29 | 2005-12-20 | 학교법인고려중앙학원 | A solely pollen-specific promoter |
WO2005100575A2 (en) * | 2004-04-14 | 2005-10-27 | Bayer Bioscience N.V. | Rice pollen-specific promoters and uses thereof |
UA113493C2 (en) | 2010-01-22 | 2017-02-10 | METHOD OF REMOVAL OF A DNA SECTION IN A PLANT | |
CN102010864B (en) * | 2010-12-14 | 2012-10-17 | 安徽农业大学 | Maize Pollen Tissue-Specific Promoter and Its Expression Vector |
CN102533761B (en) * | 2011-12-12 | 2013-03-20 | 华中科技大学 | Pollen-specific promoter and expression vector and application thereof |
US9359614B2 (en) | 2012-02-01 | 2016-06-07 | Dow Agrosciences Llc | Class of glyphosate resistance genes |
KR102076719B1 (en) | 2012-02-02 | 2020-02-12 | 다우 아그로사이언시즈 엘엘씨 | Plant transactivation interaction motifs and uses thereof |
CN104204209A (en) | 2012-03-13 | 2014-12-10 | 先锋国际良种公司 | Genetic reduction of male fertility in plants |
CA2867385A1 (en) * | 2012-03-13 | 2013-09-19 | Pioneer Hi-Bred International, Inc. | Genetic reduction of male fertility in plants |
US10155961B2 (en) | 2012-03-13 | 2018-12-18 | Pioneer Hi-Bred International. Inc. | Genetic reduction of male fertility in plants |
AU2013205557B2 (en) | 2012-04-17 | 2016-04-21 | Corteva Agriscience Llc | Synthetic brassica-derived chloroplast transit peptides |
UA118090C2 (en) | 2012-09-07 | 2018-11-26 | ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі | Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks |
RU2665811C2 (en) | 2012-09-07 | 2018-09-04 | ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи | Fad3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks |
CN102864166B (en) * | 2012-09-07 | 2014-04-09 | 江苏大学 | Specific expression method of beta-D-glucuronidase gene on stigma and torus of plant |
JP6385644B2 (en) * | 2013-03-13 | 2018-09-05 | 静岡県公立大学法人 | Optical switch construct for expressing the target gene |
CN104837334B (en) * | 2013-05-23 | 2017-06-23 | 深圳市作物分子设计育种研究院 | The new maintainer of plant and sterile line foundation and application thereof |
CN109593778A (en) * | 2018-11-08 | 2019-04-09 | 浙江大学 | A kind of plant artificial intelligence male sterile line and application |
CN110093354B (en) * | 2019-04-17 | 2020-06-05 | 湖南杂交水稻研究中心 | Seed sorting method for fixing plant heterosis |
KR20220110739A (en) | 2019-10-30 | 2022-08-09 | 페어와이즈 플랜츠 서비시즈, 인크. | Type V CRISPR-CAS base editors and methods of use thereof |
US11926834B2 (en) | 2019-11-05 | 2024-03-12 | Pairwise Plants Services, Inc. | Compositions and methods for RNA-encoded DNA-replacement of alleles |
US11976278B2 (en) | 2019-12-06 | 2024-05-07 | Pairwise Plants Services, Inc. | Recruitment methods and compounds, compositions and systems for recruitment |
CN111139257B (en) * | 2020-01-15 | 2022-10-14 | 南京农业大学 | A method for in vitro expression of pear PMEI protein and its application |
US20210238598A1 (en) | 2020-01-30 | 2021-08-05 | Pairwise Plants Services, Inc. | Compositions, systems, and methods for base diversification |
CN115335392A (en) | 2020-01-31 | 2022-11-11 | 成对植物服务股份有限公司 | Suppression of plant shade-avoidance response |
WO2021158798A1 (en) | 2020-02-04 | 2021-08-12 | Pairwise Plants Services, Inc. | Thornless / prickleless rubus plants |
EP4107274A1 (en) | 2020-02-21 | 2022-12-28 | Pairwise Plants Services, Inc. | Improved resistance to soybean cyst nematode through gene editing |
WO2021188526A1 (en) | 2020-03-16 | 2021-09-23 | Pairwise Plants Services, Inc. | Natural guide architectures and methods of making and using the same |
US11999946B2 (en) | 2020-03-26 | 2024-06-04 | Pairwise Plants Services, Inc. | Methods for controlling meristem size for crop improvement |
US11882808B2 (en) | 2020-03-27 | 2024-01-30 | Pairwise Plants Services, Inc. | Methods for improving resistance to soybean rust |
WO2021207148A1 (en) | 2020-04-06 | 2021-10-14 | Pairwise Plants Services, Inc. | Methods and compositions for increasing resistance to ear rot and stem rot disease in maize |
EP4135512A1 (en) | 2020-04-16 | 2023-02-22 | Pairwise Plants Services, Inc. | Methods for controlling meristem size for crop improvement |
MX2022015107A (en) | 2020-06-02 | 2023-03-01 | Pairwise Plants Services Inc | Methods for controlling meristem size for crop improvement. |
WO2021257775A1 (en) | 2020-06-17 | 2021-12-23 | Pairwise Plants Services, Inc. | Methods for controlling meristem size for crop improvement |
CN116113694A (en) | 2020-06-30 | 2023-05-12 | 成对植物服务股份有限公司 | Compositions, systems, and methods for base diversity |
EP4204436A1 (en) | 2020-08-28 | 2023-07-05 | Pairwise Plants Services, Inc. | Engineered crispr-cas proteins and methods of use thereof |
AU2021374974A1 (en) | 2020-11-06 | 2023-05-25 | Pairwise Plants Services, Inc. | Compositions and methods for rna-encoded dna-replacement of alleles |
US20220259612A1 (en) | 2021-02-11 | 2022-08-18 | Pairwise Plants Services, Inc. | Methods and compositions for modifying cytokinin oxidase levels in plants |
US20220380792A1 (en) | 2021-02-25 | 2022-12-01 | Pairwise Plants Services, Inc | Methods and compositions for modifying root architecture in plants |
US20220403475A1 (en) | 2021-06-14 | 2022-12-22 | Pairwise Plants Services, Inc. | Reporter constructs, compositions comprising the same, and methods of use thereof |
CN117897050A (en) | 2021-06-17 | 2024-04-16 | 成对植物服务股份有限公司 | Modification of Growth Regulator Family Transcription Factors in Soybean |
UY39827A (en) | 2021-06-24 | 2023-01-31 | Pairwise Plants Services Inc | MODIFICATION OF UBIQUITIN LIGASE E3 HECT GENES TO IMPROVE PERFORMANCE TRAITS |
CN117794358A (en) | 2021-07-01 | 2024-03-29 | 成对植物服务股份有限公司 | Methods and compositions for enhancing root development |
US20230078990A1 (en) | 2021-08-12 | 2023-03-16 | Pairwise Plants Services, Inc. | Modification of brassinosteroid receptor genes to improve yield traits |
US20230063927A1 (en) | 2021-08-17 | 2023-03-02 | Pairwise Plants Services, Inc. | Methods and compositions for modifying cytokinin receptor histidine kinase genes in plants |
MX2024002276A (en) | 2021-08-30 | 2024-03-07 | Pairwise Plants Services Inc | Modification of ubiquitin binding peptidase genes in plants for yield trait improvement. |
AR126938A1 (en) | 2021-09-02 | 2023-11-29 | Pairwise Plants Services Inc | METHODS AND COMPOSITIONS TO IMPROVE PLANT ARCHITECTURE AND PERFORMANCE TRAITS |
WO2023049728A1 (en) | 2021-09-21 | 2023-03-30 | Pairwise Plants Services, Inc. | Color-based and/or visual methods for identifying the presence of a transgene and compositions and constructs relating to the same |
CA3232804A1 (en) | 2021-09-21 | 2023-03-30 | Pairwise Plants Services, Inc. | Methods and compositions for reducing pod shatter in canola |
WO2023060028A1 (en) | 2021-10-04 | 2023-04-13 | Pairwise Plants Services, Inc. | Methods for improving floret fertility and seed yield |
WO2023060152A2 (en) | 2021-10-07 | 2023-04-13 | Pairwise Plants Services, Inc. | Methods for improving floret fertility and seed yield |
AR127904A1 (en) | 2021-12-09 | 2024-03-06 | Pairwise Plants Services Inc | METHODS TO IMPROVE FLOWER FERTILITY AND SEED YIELD |
WO2023114750A1 (en) | 2021-12-13 | 2023-06-22 | Pairwise Plants Services, Inc. | Model editing systems and methods relating to the same |
WO2023133440A1 (en) | 2022-01-06 | 2023-07-13 | Pairwise Plants Services, Inc. | Methods and compositions for trichome removal |
AR128372A1 (en) | 2022-01-31 | 2024-04-24 | Pairwise Plants Services Inc | SUPPRESSION OF THE SHADE AVOIDANCE RESPONSE IN PLANTS |
US20230383271A1 (en) | 2022-02-28 | 2023-11-30 | Pairwise Plants Services, Inc. | Engineered proteins and methods of use thereof |
US20240327858A1 (en) | 2022-03-02 | 2024-10-03 | Pairwise Plants Services, Inc. | Modification of brassinosteroid receptor genes to improve yield traits |
WO2023192838A1 (en) | 2022-03-31 | 2023-10-05 | Pairwise Plants Services, Inc. | Early flowering rosaceae plants with improved characteristics |
US20230357789A1 (en) | 2022-04-07 | 2023-11-09 | Pairwise Plants Services, Inc. | Methods and compositions for improving resistance to fusarium head blight |
US20230383305A1 (en) | 2022-04-21 | 2023-11-30 | Pairwise Plants Services, Inc. | Methods and compositions for improving yield traits |
CN119452082A (en) | 2022-05-02 | 2025-02-14 | 成对植物服务股份有限公司 | Methods and compositions for improving yield and disease resistance |
WO2023215809A1 (en) | 2022-05-05 | 2023-11-09 | Pairwise Plants Services, Inc. | Methods and compositions for modifying root architecture and/or improving plant yield traits |
AR129709A1 (en) | 2022-06-27 | 2024-09-18 | Pairwise Plants Services Inc | METHODS AND COMPOSITIONS TO MODIFY SHADE ESCAPE IN PLANTS |
WO2024006792A1 (en) | 2022-06-29 | 2024-01-04 | Pairwise Plants Services, Inc. | Methods and compositions for controlling meristem size for crop improvement |
US20240000031A1 (en) | 2022-06-29 | 2024-01-04 | Pairwise Plants Services, Inc. | Methods and compositions for controlling meristem size for crop improvement |
WO2024030984A1 (en) | 2022-08-04 | 2024-02-08 | Pairwise Plants Services, Inc. | Methods and compositions for improving yield traits |
WO2024036240A1 (en) | 2022-08-11 | 2024-02-15 | Pairwise Plants Services, Inc. | Methods and compositions for controlling meristem size for crop improvement |
WO2024054880A1 (en) | 2022-09-08 | 2024-03-14 | Pairwise Plants Services, Inc. | Methods and compositions for improving yield characteristics in plants |
US20240200102A1 (en) | 2022-12-16 | 2024-06-20 | Pairwise Plants Services, Inc. | Fusion proteins comprising an intein polypeptide and methods of use thereof |
WO2024137911A1 (en) | 2022-12-21 | 2024-06-27 | Pairwise Plants Services, Inc. | Engineered proteins and methods of use thereof |
US20240279673A1 (en) | 2023-02-16 | 2024-08-22 | Pairwise Plants Services, Inc. | Methods and compositions for modifying shade avoidance in plants |
US20240327811A1 (en) | 2023-03-01 | 2024-10-03 | Pairwise Plants Services, Inc. | Engineered proteins and methods of use thereof |
WO2024182658A1 (en) | 2023-03-02 | 2024-09-06 | Pairwise Plants Services, Inc. | Methods and compositions for modifying shade avoidance in plants |
WO2024186950A1 (en) | 2023-03-09 | 2024-09-12 | Pairwise Plants Services, Inc. | Modification of brassinosteroid signaling pathway genes for improving yield traits in plants |
WO2024206375A1 (en) | 2023-03-30 | 2024-10-03 | Pairwise Plants Services, Inc. | Methods and compositions for reducing thorns or prickles in plants |
US20240384280A1 (en) | 2023-05-18 | 2024-11-21 | Pairwise Plants Services, Inc. | Methods and compositions for improving yield characteristics in plants |
WO2025019522A1 (en) | 2023-07-18 | 2025-01-23 | Pairwise Plants Services, Inc. | Methods and compositions for modifying root architecture in plants |
US20250034583A1 (en) | 2023-07-27 | 2025-01-30 | Pairwise Plants Services, Inc. | Methods and compositions for modifying plant yield traits |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8901677D0 (en) * | 1989-01-26 | 1989-03-15 | Ici Plc | Hybrid seed production |
EP0644943B1 (en) * | 1992-06-12 | 2005-10-05 | Bayer BioScience N.V. | Maintenance of male-sterile plants |
GB9515161D0 (en) * | 1995-07-24 | 1995-09-20 | Zeneca Ltd | Production of male sterile plants |
CA2234557C (en) * | 1995-10-13 | 2007-01-09 | Purdue Research Foundation | Method for the production of hybrid plants |
GB9607517D0 (en) * | 1996-04-11 | 1996-06-12 | Gene Shears Pty Ltd | The use of DNA Sequences |
WO1999008830A1 (en) * | 1997-08-18 | 1999-02-25 | Zakrytoe Aktsionernoe Obschestvo 'firma Novye Sistemnye Tekhnologii' | Method of laser welding of thin sheet metallic components |
-
1999
- 1999-01-22 CA CA002319079A patent/CA2319079A1/en not_active Abandoned
- 1999-01-22 IL IL13797199A patent/IL137971A0/en unknown
- 1999-01-22 HU HU0100787A patent/HUP0100787A3/en not_active Application Discontinuation
- 1999-01-22 EP EP99902660A patent/EP1054970A1/en not_active Withdrawn
- 1999-01-22 KR KR1020007009173A patent/KR20010041129A/en not_active Application Discontinuation
- 1999-01-22 AU AU22876/99A patent/AU751438B2/en not_active Ceased
- 1999-01-22 CN CN99805265A patent/CN1301300A/en active Pending
- 1999-01-22 BR BR9907997-6A patent/BR9907997A/en not_active IP Right Cessation
- 1999-01-22 WO PCT/GB1999/000232 patent/WO1999042587A1/en not_active Application Discontinuation
- 1999-01-22 JP JP2000532527A patent/JP2002504335A/en active Pending
- 1999-02-17 DZ DZ990026A patent/DZ2725A1/en active
Also Published As
Publication number | Publication date |
---|---|
EP1054970A1 (en) | 2000-11-29 |
AU751438B2 (en) | 2002-08-15 |
BR9907997A (en) | 2000-10-24 |
KR20010041129A (en) | 2001-05-15 |
DZ2725A1 (en) | 2003-09-01 |
CN1301300A (en) | 2001-06-27 |
IL137971A0 (en) | 2001-10-31 |
JP2002504335A (en) | 2002-02-12 |
HUP0100787A2 (en) | 2002-04-29 |
AU2287699A (en) | 1999-09-06 |
WO1999042587A1 (en) | 1999-08-26 |
HUP0100787A3 (en) | 2003-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU751438B2 (en) | Pollen specific promoter | |
EP0329308B1 (en) | Antisense gene systems of pollination control for hybrid seed production | |
CA2008700C (en) | Hybrid seed production | |
US5356799A (en) | Antisense gene systems of pollination control for hybrid seed production | |
US5583210A (en) | Methods and compositions for controlling plant development | |
JP3143120B2 (en) | Plants with altered flowers, seeds or germs | |
Yamamoto et al. | A male sterility‐associated mitochondrial protein in wild beets causes pollen disruption in transgenic plants | |
AU654314B2 (en) | Tapetum-specific promoters from brassicaceae SPP | |
JP2002354954A (en) | Reversible nuclear genetic system for male sterility in transgenic plants | |
JP2000116258A (en) | Method for producing hybrid seed by dual latent cytotoxicity method | |
AU708618B2 (en) | Induction of male sterility in plants by expression of high levels of avidin | |
EP1054985B1 (en) | Hybrid seed production | |
MXPA99008098A (en) | Method of hybrid seed production using conditional female sterility | |
US6545201B1 (en) | Leafy cotyledon1 genes and their uses | |
US5728926A (en) | Antisense gene systems of pollination control for hybrid seed production | |
WO2022109764A1 (en) | Fertility-related gene and application thereof in hybrid breeding | |
US20040045053A1 (en) | Pollen specific promoter | |
US20220275383A1 (en) | Sterile genes and related constructs and applications thereof | |
CA2376437A1 (en) | Promoter system and production and use of the same | |
MXPA00007829A (en) | Pollen specific promoter | |
US7094958B2 (en) | Rice α-amylase transcriptional enhancers | |
WO2001037643A1 (en) | Method for lowering pollen fertility by using pollen-specific zinc finger transcriptional factor genes | |
CA2274983A1 (en) | Meiosis-related gene and promoter | |
WO2018205521A1 (en) | Wheat fertility-related gene tams7 and application method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |